iShares Bitcoin Trust vs IDEXX Laboratories, Inc. — how do they compare? iShares Bitcoin Trust trades at $35.88, while IDEXX Laboratories, Inc. trades at $571.99 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is trading nearer its 52-week high, iShares Bitcoin Trust nearer its low. Which is the better fit depends on your goals.
| IBIT | IDXX | |
|---|---|---|
Sector | Crypto-linked | Health |
52-Week High | $71.29 | $766.68 |
52-Week Low | $33.29 | $526.44 |
Market Cap | — | $46.22B |
Enterprise Value | — | $47.12B |
Signals from Pluang's Aura AI — not financial advice
IBIT trades at $35.9, down 0.91% on the day, reflecting a bearish technical outlook with moving averages signaling strong selling pressure. The stock faces resistance at $36 and $37, with support at $35. Recent news highlights institutional interest, with Alpha Zero LLC increasing its stake by 43.8% in Q1 2026 (SEC filing, 2026-07-21).
The outlook remains cautious due to the bearish technical structure and lack of fundamental financial data. Key risks include market volatility and competitive pressures. Analyst sentiment is mixed, with some advocating long-term value while technical indicators suggest near-term weakness.
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
Trailing returns across standard periods
Latest headlines on both assets
IBIT is a spot Bitcoin ETF that tracks the price of Bitcoin directly. Managed by BlackRock, it offers investors a regulated way to gain exposure to the digital asset within a traditional brokerage account.
Read more on IBIT →Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →